(WIAT) — Careful! The FDA has released a company announcement that a series of birth control tablets have been recalled for a packaging error. The company Apotex Corporation issued a voluntary nationwide recall for Drospirenone and Ethinyl Estradiol Tablets, USP 28×3 Blister Pack/Carton due to a missing and/or incorrect tablet arrangement. Drospirenone and Ethinyl Estradiol Tablets, USP are an estrogen/progestin COC indicated for use by women to prevent pregnancy.
The company states,
Risk Statement: As a result of this packaging error, where a patient does not take a tablet due to a missing tablet or that a patient takes a placebo instead of an active tablet, loss of efficacy is possible due to variation in the dosage consumed. To date, no case has been reported for pregnancy and adverse event to Apotex.
Here are the recalled serial numbers:
The FDA suggests that patients taking this form of birth control should contact their pharmacist and to not interrupt their therapy, nor use a non-hormonal method of birth control. Instead, patients should contact their health care provider for medical advice.
For more information on this recall, click here.